Announcements Trials
Browse Landscape

Phase

Phase 2 40Phase 1 20Phase NA 10Phase 1/2 9Phase 3 6Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 2Lymphoma, Large B-Cell, Diffuse 2Waldenstrom Macroglobulinemia 1Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Brain Neoplasms 1

Interventions

Cyclophosphamide 4Rituximab 3ibrutinib 2Peripheral Blood Stem Cell Transplantation 2venetoclax 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1ibritumomab tiuxetan 1fludarabine phosphate 1fludarabine 1brexucabtagene autoleucel 1acalabrutinib 1Vincristine 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Sirolimus 1Ribavirin 1Precision Medicine 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Pemetrexed 1NVP-BKM120 1Methotrexate 1Loratadine 1Immunohistochemistry 1Immunoenzyme Techniques 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, Mantle-Cell × Filgrastim × Clear all
NCT00017381 2013-01-09

Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase EARLY_PHASE1 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡